TheEdgeResearch
Home / Stocks / IDGXF

Integrated Diagnostics Holdings plc (IDGXF)

OTC Healthcare Medical - Diagnostics & Research
$0.60 ▲ +0.00%
Market Cap
$349.4M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.42
52-Wk Range
0.47-0.6983
CEO
Hend El Sherbini
Country
JE
Currency
USD

Integrated Diagnostics Holdings plc operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Saint Helier, GZ, JE. The stock last traded at $0.60, up 0.00% on the session, giving a market capitalisation of $349.4M. On trailing twelve-month figures it carries a trailing P/E of 9.70, a net margin of 16.5%. Its beta of 0.42 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
9.70
Price / Sales
1.59
Price / Book
3.72
EV / EBITDA
5.08
Gross margin
43.3%
Operating margin
28.1%
Net margin
16.5%
Return on equity
—
Debt / equity
0.43
Current ratio
1.67
Dividend yield
1.8%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
6,309
IPO date
2019-06-03
Headquarters
Saint Helier, GZ, JE
About Integrated Diagnostics Holdings plc

Integrated Diagnostics Holdings plc (IDHC.L) functions as a leading consumer healthcare enterprise, offering a wide array of medical diagnostic services directly to its clientele. The company's comprehensive service catalog features around 2,000 distinct diagnostic examinations, spanning specialized fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. Geographically, IDHC has established operations across Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, its infrastructure included an extensive network of 452 laboratory branches. The organization was founded in 1979 and maintains its corporate headquarters in Saint Helier, Jersey.

More research on IDGXF
IDGXF technical analysis IDGXF TheEdge Score Compare against peers
Open full interactive analysis & DCF →